Warning Letter Roundup: U.S. Firms Hit for GMPs, Other Letdowns By Sam | January 13, 2020 Four U.S. drugmakers drew FDA warning letters for violations ranging from the use of contaminated water to the promotion of unapproved drug products. Source: Drug GMP Report Posted in Drug GMP Report